Clinical spectrum and mechanism of acute kidney injury in patients with diabetes mellitus on SGLT-2 inhibitors

Medicine & Life Sciences

• Sodium-Glucose Transporter 2 Inhibitors 100%
• Sodium-Glucose Transport Proteins 98%
• Acute Kidney Injury 65%
• Diabetes Mellitus 54%
• Type 2 Diabetes Mellitus 25%
• Canagliflozin 13%
• empagliflozin 13%
• Marketing 9%
• Kidney 9%
• Renin-Angiotensin System 8%
• Glomerular Filtration Rate 8%
• Contrast Media 7%
• Diarrhea 7%
• Sepsis 6%
• Hypoxia 6%
• Anti-Inflammatory Agents 6%
• Retrospective Studies 5%
• Databases 5%
• Injections 4%
• Pharmaceutical Preparations 3%

Chemistry

• Nephrotoxic Agent 70%
• Empagliflozin 65%
• Canagliflozin 64%
• Filtration 59%
• Glycemic 53%
• Nonsteroid Antiinflammatory Agent 39%
• Label 30%

Engineering & Materials Science

• Glucose 78%
• Medical problems 75%
• Sodium 70%
• Marketing 8%
• Labels 7%